DRW Securities’s Bionano Genomics BNGO Stock Holding History

DRW Securities’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-168,453	Closed	-$258K	–	1314
2025 Q4	$258K	Buy	+168,453	New	+$292K	0.01%	771

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

DRW Securities's BNGO Position: Q1 2026 in Review

DRW Securities sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 168,453 shares — an estimated $258K sold.

DRW Securities first reported a position in BNGO in Q4 2025 and held it in 1 quarter. The position peaked at $258K in Q4 2025. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

DRW Securities reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 168,453 Bionano Genomics shares in Q1 2026, an estimated $258K.
DRW Securities first reported a position in Bionano Genomics in Q4 2025 and held it in 1 quarter.
DRW Securities's Bionano Genomics position peaked at $258K in Q4 2025.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.